Effects of safinamide on pain in patients with fluctuating Parkinson's disease

Abstract Background Non‐motor symptoms (NMS) are integral to Parkinson's Disease (PD) and management remains a challenge. Safinamide is a novel molecule in relation to addressing NMS due to its multifocal mechanism of action with both dopaminergic and non‐dopaminergic properties. Objective To i...

Full description

Bibliographic Details
Main Authors: Sotirios Grigoriou, Pablo Martínez‐Martín, K. Ray Chaudhuri, Katarina Rukavina, Valentina Leta, Denise Hausbrand, Björn Falkenburger, Per Odin, Heinz Reichmann
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:Brain and Behavior
Subjects:
Online Access:https://doi.org/10.1002/brb3.2336